Additionally, screening of approximately 2000 compounds showed that compared to their venetoclax-sensitive parental cells, venetoclax-resistant DLBCL cells had increased sensitivity to mubritinib, initially thought to be a HER2 inhibitor [50], but subsequently shown to inhibit the mitochondrial electron transport chain (ETC; [51]) (Figure 3A, Supplementary Table S6). Here, ERBB2 is linked to diffuse large B-cell lymphoma.